Clinical Trials Browser

Phase 2 × INDUSTRY × Granisetron × Clear all

NCT01909856 2015-12-04

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Phase 2 Completed

Neoplasms